Study S001934

Effects of Mazdutide on Cognitive Function in Patients With Type 2 Diabetes and Early-Stage Cognitive Impairment: A Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled Trial

ClinicalTrials.gov record

Registration

Registration: NCT07083154
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 420
Start: 2025-09-27
Primary completion: 2029-08-01
Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions: Dementia, Mild; Mild Cognitive Impairment; Type 2 Diabetes
Interventions: DRUG:Mazdutide; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Integrated Alzheimer's Disease Rating Scale (iADRS) Score Change [From Baseline to Week 76]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.